Front Cell Dev Biol 8:690
Common Side Effects Reported Across Phase 2 trials, participants experienced dose-dependent GI symptoms that are characteristic of GLP-1 receptor agonists: Nausea most frequent, especially during dose escalation Vomiting typically mild to moderate, subsiding with continued use Diarrhea and constipation fluctuating depending on individual tolerance Abdominal discomfort transient and often improved over time Dose-Response Relationship At lower doses (14 mg weekly), side effects were generally mild and manageable, though some participants still reported early GI symptoms
Typically, patients with a deficiency might start with more frequent injections, often weekly, and then switch to monthly maintenance doses once levels stabilize
Our sauces use nuts and oils that are rich in healthy fats
This allows procurement teams to focus on research objectives rather than inventory concerns
The good news is that for most people it's tied to changes your body is still adjusting to and those changes tend to settle
)
)
